Gliomas represent over 50% of tumors occurring in children. Evidence suggests that glioma stem cells (GSCs), maintained by the transforming growth factor-beta (TGF-β1 ) pathway, and vascularization substantially contribute to tumor aggressiveness. The identification of important angiogenic factors such as vascular endothelial growth factor (VEGF) may represent a crucial step in the therapeutic approach against tumor growth and metastatic diffusion. The aim of this study was to identify the expression of TGF-β1, VEGF and VEGF-receptors in brain gliomas. Specimens of 16 gliomas and 4 controls from children aged 0.2-14 years were used in the study. Immunohistochemical analysis and gene expression study from specimens was performed. Flow cytometry analysis on GSCs was performed to ascertain the expression of VEGF and VEGF-R2 in the tumor stem cell compartment. Newly diagnosed gliomas mainly showed moderate to strong VEGF immunostaining and increased expression of pro-inflammatory molecules in glioma cells. The proportion of TGF-β1 positive endothelial cells was markedly lower in normal brain vessels compared to tumor vessels. These findings demonstrate that the glioma mass is constituted by a phenotypically immature anoxic central area with a proliferating hypoxic layer; the peripheral area is characterized by cell types with a higher degree of differentiation expressing pro-angiogenic factors. Our data have proven that GSCs play a central role in promoting glioma neovascularization. These findings are useful to understand glioma vascularization, have relevant implications in the therapeutic options and may favor new insights into stem cells biology and suggest therapeutic opportunities for the anti-vascular treatment strategy.

Taurone, S., Spoletini, M., Chiappetta, C., Di Gioia, C., Carletti, R., Greco, A., et al. (2019). Brain gliomas and growth factors: Immunohistochemical, immunofluorescence, flow cytometry and rt-pcr profile in pediatric age. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 33(5), 1451-1463.

Brain gliomas and growth factors: Immunohistochemical, immunofluorescence, flow cytometry and rt-pcr profile in pediatric age

Pastore F. S.;
2019-01-01

Abstract

Gliomas represent over 50% of tumors occurring in children. Evidence suggests that glioma stem cells (GSCs), maintained by the transforming growth factor-beta (TGF-β1 ) pathway, and vascularization substantially contribute to tumor aggressiveness. The identification of important angiogenic factors such as vascular endothelial growth factor (VEGF) may represent a crucial step in the therapeutic approach against tumor growth and metastatic diffusion. The aim of this study was to identify the expression of TGF-β1, VEGF and VEGF-receptors in brain gliomas. Specimens of 16 gliomas and 4 controls from children aged 0.2-14 years were used in the study. Immunohistochemical analysis and gene expression study from specimens was performed. Flow cytometry analysis on GSCs was performed to ascertain the expression of VEGF and VEGF-R2 in the tumor stem cell compartment. Newly diagnosed gliomas mainly showed moderate to strong VEGF immunostaining and increased expression of pro-inflammatory molecules in glioma cells. The proportion of TGF-β1 positive endothelial cells was markedly lower in normal brain vessels compared to tumor vessels. These findings demonstrate that the glioma mass is constituted by a phenotypically immature anoxic central area with a proliferating hypoxic layer; the peripheral area is characterized by cell types with a higher degree of differentiation expressing pro-angiogenic factors. Our data have proven that GSCs play a central role in promoting glioma neovascularization. These findings are useful to understand glioma vascularization, have relevant implications in the therapeutic options and may favor new insights into stem cells biology and suggest therapeutic opportunities for the anti-vascular treatment strategy.
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/27 - NEUROCHIRURGIA
English
Angiogenesis-Brain gliomas-Childhood cancers-Growth factors-IHCRT-PCR
Taurone, S., Spoletini, M., Chiappetta, C., Di Gioia, C., Carletti, R., Greco, A., et al. (2019). Brain gliomas and growth factors: Immunohistochemical, immunofluorescence, flow cytometry and rt-pcr profile in pediatric age. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 33(5), 1451-1463.
Taurone, S; Spoletini, M; Chiappetta, C; Di Gioia, C; Carletti, R; Greco, A; Agostinelli, E; Ralli, M; Giangaspero, F; Artico, M; Pastore, Fs; Scarpa, S; Gobbi, P; Di Liddo, R
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/246285
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact